+ Follow ICELAND AND NORWAY Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 833899
[Title] => Novartis cancer drug gets Phl FDA approval
[Summary] => The Novartis anti-cancer drug everolimus, in combination with aromatase inhibitor, is now approved in the Philippines for the treatment of hormone receptor-positive (HR+), HER2/neu-negative (HER2-) advanced breast cancer, in postmenopausal women after recurrence or progression following endocrine therapy.
[DatePublished] => 2012-08-02 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
ICELAND AND NORWAY
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 833899
[Title] => Novartis cancer drug gets Phl FDA approval
[Summary] => The Novartis anti-cancer drug everolimus, in combination with aromatase inhibitor, is now approved in the Philippines for the treatment of hormone receptor-positive (HR+), HER2/neu-negative (HER2-) advanced breast cancer, in postmenopausal women after recurrence or progression following endocrine therapy.
[DatePublished] => 2012-08-02 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest